Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.

Autor: Hsu EJ; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lin TA; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Dabush DR; Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel., McCaw Z; Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Koong A; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin C; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abi Jaoude J; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel R; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kouzy R; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., El Alam MB; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Noticewala S; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang Y; School of Bioinformatics, University of Texas Health Science Center at Houston, Houston, TX, USA., Sherry AD; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas CR Jr; Radiation Oncology, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, NH, USA., Tang C; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Das P; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang B; Pfizer Inc, Groton, CT, USA., Tian L; Department of Health Research and Policy, Stanford University, Stanford, CA, USA., Sun R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meirson T; Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ludmir EB; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jun 07; Vol. 116 (6), pp. 990-994.

Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.

Autor: Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCaw ZR; Insitro, South San Francisco, CA, USA; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Abi Jaoude J; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Hsu EJ; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kouzy R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Yang Y; Department of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA., Lin TA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Taniguchi CM; Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rödel C; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, Frankfurt, Germany., Fokas E; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, Frankfurt, Germany., Tang C; Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genitourinary Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Minsky B; Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meirson T; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludmir EB; Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ebludmir@mdanderson.org.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113357. Date of Electronic Publication: 2023 Sep 22.

Socioeconomic and demographic determinants of radiation treatment and outcomes in glioblastoma patients.

Autor: Hsu EJ; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States., Thomas J; Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, TX, United States., Timmerman RD; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States., Wardak Z; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States., Dan TD; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States., Patel TR; Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, TX, United States., Sanford NN; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States., Vo DT; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States.

Publikováno v: Frontiers in neurology [Front Neurol] 2022 Nov 11; Vol. 13, pp. 1024138. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2022).

3D printed integrated bolus/headrest for radiation therapy for malignancies involving the posterior scalp and neck.

Autor: Hsu EJ; Department of Radiation Oncology, Division of Clinical Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, 75390, USA., Parsons D; Department of Radiation Oncology, Division of Medical Physics and Engineering, UT Southwestern Medical Center, Dallas, TX, 75390, USA., Chiu T; Department of Radiation Oncology, Division of Medical Physics and Engineering, UT Southwestern Medical Center, Dallas, TX, 75390, USA., Godley AR; Department of Radiation Oncology, Division of Medical Physics and Engineering, UT Southwestern Medical Center, Dallas, TX, 75390, USA., Sher DJ; Department of Radiation Oncology, Division of Clinical Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, 75390, USA., Vo DT; Department of Radiation Oncology, Division of Clinical Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, 75390, USA. Dat.Vo@UTSouthwestern.edu.

Publikováno v: 3D printing in medicine [3D Print Med] 2022 Jul 18; Vol. 8 (1), pp. 22. Date of Electronic Publication: 2022 Jul 18.